Clinical Trials
94 trialsNeoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.
Shanghai Pulmonary Hospital, Shanghai, China
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
STRASS2
European Organisation for Research and Treatment of Cancer - EORTC
STEREO-SEIN
Gustave Roussy, Cancer Campus, Grand Paris
FOBEAR
Sun Yat-sen University
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
Sandoz
COnCERTO
University Hospital, Rouen
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
Minia University
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Sun Yat-sen University
Neo-CRAG
Sun Yat-sen University
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Eye & ENT Hospital of Fudan University
Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer
Assiut University
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
First Affiliated Hospital of Zhejiang University
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
Fudan University
NEOGB
Rajiv Gandhi Cancer Institute & Research Center, India
NEEDS
Karolinska University Hospital
ESCC
Sichuan Cancer Hospital and Research Institute
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
ESOPEC
University Hospital Schleswig-Holstein
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Sichuan Cancer Hospital and Research Institute
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
St. James's Hospital, Ireland
CAIRO4
Dutch Colorectal Cancer Group
TaLaR-02
Sun Yat-sen University
DART
Canadian Cancer Trials Group
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
Children's Oncology Group
SHIP0804
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
COLLISION RELAPSE Trial
Amsterdam UMC, location VUmc
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
Fudan University
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
HCHTOG1903
Henan Cancer Hospital
NATCH
Spanish Lung Cancer Group
KEYSTONE-002
Tianjin Medical University Cancer Institute and Hospital
Neoadjuvant Chemotherapy in Cervical Cancer
Banaras Hindu University
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Fudan University
STELLAR
ChineseAMS
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Delcath Systems Inc.
Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy
Mansoura University
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
UNICANCER
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
UNICANCER
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
UNICANCER
AADLPC
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
Swiss Cancer Institute
SCORPION
Catholic University of the Sacred Heart
FOCUS
Shanghai Gynecologic Oncology Group
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Celgene
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
Federation Francophone de Cancerologie Digestive
COMPETE
Ruijin Hospital
NEO-ZOTAC
Borstkanker Onderzoek Groep